Cargando…

Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia

INTRODUCTION: Drivers of adverse perinatal outcomes in pregnancies of women receiving chronic kidney replacement therapy (KRT) remain poorly understood. METHODS: Births ≥ 20 weeks of gestation in Australian women receiving KRT were analyzed for perinatal outcomes stratified by maternal KRT exposure...

Descripción completa

Detalles Bibliográficos
Autores principales: Hewawasam, Erandi, Davies, Christopher E., Li, Zhuoyang, Clayton, Philip, Sullivan, Elizabeth, McDonald, Stephen P., Jesudason, Shilpanjali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171625/
https://www.ncbi.nlm.nih.gov/pubmed/35685315
http://dx.doi.org/10.1016/j.ekir.2022.03.015
_version_ 1784721709292584960
author Hewawasam, Erandi
Davies, Christopher E.
Li, Zhuoyang
Clayton, Philip
Sullivan, Elizabeth
McDonald, Stephen P.
Jesudason, Shilpanjali
author_facet Hewawasam, Erandi
Davies, Christopher E.
Li, Zhuoyang
Clayton, Philip
Sullivan, Elizabeth
McDonald, Stephen P.
Jesudason, Shilpanjali
author_sort Hewawasam, Erandi
collection PubMed
description INTRODUCTION: Drivers of adverse perinatal outcomes in pregnancies of women receiving chronic kidney replacement therapy (KRT) remain poorly understood. METHODS: Births ≥ 20 weeks of gestation in Australian women receiving KRT were analyzed for perinatal outcomes stratified by maternal KRT exposure (dialysis or transplant, analyzed separately), by linking the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and perinatal data sets (1991–2013). RESULTS: Of 2,948,084 babies (1,628,181 mothers), 248 were born to mothers receiving KRT (transplant, n = 211; dialysis, n = 37), with live birth rates ≥ 94%. The perinatal death rate was 162, 62, and 9 per 1000 births in the dialysis, transplant, and non-KRT cohorts, respectively. Babies exposed to KRT had increased odds of prematurity, small-for-gestational age (SGA), poor birth condition, resuscitation, intensive care admission, and longer hospitalization, with the dialysis cohort having worse outcomes. Preterm babies of dialyzed and transplanted mothers (compared with preterm babies with no KRT exposure) experienced 1.6- to 2.7-fold higher odds for all adverse outcomes, except birthweight < 2500 g, which was 11-fold higher for the dialysis cohort. In adjusted analyses, transplanted women with better allograft function (serum creatinine ≤ 120 μmol/l) still had >10-fold higher odds of preterm birth and low birthweight and 1.8- to 4.6-fold increased odds of other adverse outcomes. In transplanted women, mediation analysis revealed that pregnancy-induced hypertension contributed only a modest proportional effect (2.5%–11.2%) on adverse outcomes. CONCLUSION: Maternal dialysis and transplantation conferred excess perinatal morbidity, particularly for preterm babies, and even in women with good preconception allograft function. Pregnancy-induced hypertension is not the predominant determinant of perinatal morbidity. Preconception counseling of women with kidney disease should encompass discussion of perinatal complications.
format Online
Article
Text
id pubmed-9171625
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91716252022-06-08 Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia Hewawasam, Erandi Davies, Christopher E. Li, Zhuoyang Clayton, Philip Sullivan, Elizabeth McDonald, Stephen P. Jesudason, Shilpanjali Kidney Int Rep Clinical Research INTRODUCTION: Drivers of adverse perinatal outcomes in pregnancies of women receiving chronic kidney replacement therapy (KRT) remain poorly understood. METHODS: Births ≥ 20 weeks of gestation in Australian women receiving KRT were analyzed for perinatal outcomes stratified by maternal KRT exposure (dialysis or transplant, analyzed separately), by linking the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and perinatal data sets (1991–2013). RESULTS: Of 2,948,084 babies (1,628,181 mothers), 248 were born to mothers receiving KRT (transplant, n = 211; dialysis, n = 37), with live birth rates ≥ 94%. The perinatal death rate was 162, 62, and 9 per 1000 births in the dialysis, transplant, and non-KRT cohorts, respectively. Babies exposed to KRT had increased odds of prematurity, small-for-gestational age (SGA), poor birth condition, resuscitation, intensive care admission, and longer hospitalization, with the dialysis cohort having worse outcomes. Preterm babies of dialyzed and transplanted mothers (compared with preterm babies with no KRT exposure) experienced 1.6- to 2.7-fold higher odds for all adverse outcomes, except birthweight < 2500 g, which was 11-fold higher for the dialysis cohort. In adjusted analyses, transplanted women with better allograft function (serum creatinine ≤ 120 μmol/l) still had >10-fold higher odds of preterm birth and low birthweight and 1.8- to 4.6-fold increased odds of other adverse outcomes. In transplanted women, mediation analysis revealed that pregnancy-induced hypertension contributed only a modest proportional effect (2.5%–11.2%) on adverse outcomes. CONCLUSION: Maternal dialysis and transplantation conferred excess perinatal morbidity, particularly for preterm babies, and even in women with good preconception allograft function. Pregnancy-induced hypertension is not the predominant determinant of perinatal morbidity. Preconception counseling of women with kidney disease should encompass discussion of perinatal complications. Elsevier 2022-03-23 /pmc/articles/PMC9171625/ /pubmed/35685315 http://dx.doi.org/10.1016/j.ekir.2022.03.015 Text en Crown Copyright © 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Hewawasam, Erandi
Davies, Christopher E.
Li, Zhuoyang
Clayton, Philip
Sullivan, Elizabeth
McDonald, Stephen P.
Jesudason, Shilpanjali
Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia
title Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia
title_full Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia
title_fullStr Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia
title_full_unstemmed Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia
title_short Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia
title_sort determinants of perinatal outcomes in dialyzed and transplanted women in australia
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171625/
https://www.ncbi.nlm.nih.gov/pubmed/35685315
http://dx.doi.org/10.1016/j.ekir.2022.03.015
work_keys_str_mv AT hewawasamerandi determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia
AT davieschristophere determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia
AT lizhuoyang determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia
AT claytonphilip determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia
AT sullivanelizabeth determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia
AT mcdonaldstephenp determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia
AT jesudasonshilpanjali determinantsofperinataloutcomesindialyzedandtransplantedwomeninaustralia